Sizing Up the Pre-Earnings Action
Pfizer (PFE) is a current long holding and the biggest name to report earnings before the bell tomorrow. Although this has been a slow but steady breakout name, I'm not expecting much on the earnings front as far as price movement goes. I think just $0.25 to maybe $0.50 is about all we see out of this giant. I'll be a buyer on any pullback to $26, but I'll still be interested in a trade if Pfizer drops to $26.50 and holds. I don't plan to trade this one before earnings.
I don't plan to take a position in VMWare (VMW) before earnings, but this will be one I will watch closely in the after-hours session and into tomorrow's trading. Options are looking for about an $8 move into February expiration. While that is altogether possible, I don't like playing it into earnings. The targets here look like $103 and $94, only about $4 to $4.50 away from the current price....272 more words left in this article. To read them, just click below and try Real Money FREE for 14 days.
There’s no substitute for a trading floor to get great ideas, so Jim Cramer created a better one at Real Money and blogs there exclusively. We then added legendary hedge fund manager, Doug Kass, with his exclusive Daily Diary and best investing ideas. Staffed with more than 4 dozen investing pros, money managers, journalists and analysts, Real Money Pro gives you a flood of opinions, analysis and actionable trading advice found nowhere else, and allows you to interact directly with each expert.
Already a Subscriber? Please login.